Overview

Intravenous Versus Subcutaneous Administration of Low Molecular Weight Heparin for Thromboprophylaxis in Critically Ill Patients

Status:
Completed

Trial end date:
2020-12-31

Target enrollment:

Participant gender:

Summary

Objective: To compare the pharmacokinetic profiles of intravenous versus subcutaneous route of administration of LMWH for thromboprophylaxis in critically ill patients

Phase:

Phase 4

Details

Lead Sponsor:

Clinique Saint Pierre Ottignies

Treatments:

Nadroparin